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October 20121180 AbstractsComparison of Long-term Survival After Open vs Endovascular Repair
of Intact Abdominal Aortic Aneurysm Among Medicare Beneficiaries
Jackson RS., Chang DC., Freischlag JA.. JAMA 2012;307:1621-8.
Conclusion: In Medicare beneficiaries, repair of isolated, intact ab-
dominal aortic aneurysms (AAA) by endovascular means is associated with a
lower risk of all-cause mortality and AAA-related mortality than repair using
open techniques.
Summary: Randomized clinical trials (RCTs) have failed to demon-
strate a long-term survival advantage of endovascular repair vs open repair of
AAA. Furthermore, a previous study of Medicare beneficiaries undergoing
AAA repair between 2001 and 2004 also failed to demonstrate a survival
advantage of endovascular repair over open repair beyond 3 years of
follow-up (Schemerhorn ML et al, N Engl J Med 2008;358:464-74). It is
possible current endovascular devices may provide improved overall results
of endovascular repair than those available for analysis of endovascular vs
open AAA repair in the previous study of Medicare beneficiaries. The
authors, therefore, decided to compare overall and AAA-specific mortality,
readmission, and reintervention after endovascular vs open repair of non-
ruptured AAAs in Medicare beneficiary patients using a database from 2003
to 2007. This was a retrospective analysis of patients aged 65 years in the
Medicare standard analytic file, 2003 to 2007, who underwent isolated
repair of an intact AAA. The national death index was used to determine
cause of death. Primary outcome was all-cause mortality. Secondary out-
comes were AAA-related mortality, hospital length of stay, 1-year readmis-
sion, repeat AAA repair, incisional hernia repair, and lower extremity ampu-
tation. The Medicare standard analytic files contained data from a 5%
example of Medicare inpatient discharges. The study included 4029 pa-
tients; of these, 703 underwent open repair and 3826 underwent endovas-
cular repair. Mean and median follow-up times were 2.6 (SD, 1.5) and 2.5
(interquartile range, 2.4) years, respectively. After adjusting for emergency
admission, age, calendar year, sex, race, and comorbidities, there was a
higher risk of both all-cause mortality (hazard ratio, 1.24; 95% confidence
interval [CI], 1.05-1.47; P  .01) and AAA-related mortality after open vs
endovascular repair (hazard ratio, 4.37l; 95% CI, 2.51-7.66; P  .001).
Adjusted hospital length of stay averaged 6.5 days (95% CI, 6.0-7.0 days;
P  .001) longer after open repair (mean, 10.4 days) compared with
endovascular repair (mean, 3.6 days). Need for incisional hernia repair was
higher after open AAA (P .001). The 1-year readmission rates, repeat AAA
repair, and lower extremity amputation did not differ by repair type.
Comment: The data presented here do not demonstrate inferiority of
endovascular vs open AAA repair. However, there are really too many
deficiencies in the data to justify a conclusion that the data demonstrate
superiority of endovascular vs open repair of AAAs. First, follow-up is
relatively short and the number of patients analyzed quite small compared
with the number potentially available for analysis. In addition, the Medicare
database does not contain information about aneurysm configuration and
other anatomic factors that may influence surgeon choice of endovascular or
open repair. Given the general acceptance of endovascular repair, it is quite
likely many—if not most—of the patients undergoing open repair were
judged not suitable for endovascular repair. The report compares survival
after open or endovascular repair but not necessarily in patients suitable for
either open or endovascular repair. The report does not adequately address
reinterventions. Most patients undergo reinterventions for failure of endo-
vascular repair as outpatients, which was not analyzed in this study, and
reinterventions for open and endovascular aneurysm graft-related failure
requiring readmission tend to occur beyond the median follow-up of this
report (Kelso RL et al, J Vasc Surg 2009;49:589-95; and Brinster CJ et al, J
Vasc Surg 2011;54:42-6). The most reasonable conclusion provided by the
data is that endovascular repair as a form of management of AAA is a
reasonable approach for management of anatomically suitable patients with
AAA who are Medicare beneficiaries. The data are not suitable for cost-
analysis or analysis of all relevant reinterventions.
Long Term Outcomes in Men Screened for Abdominal Aortic Aneu-
rysm: Prospective Cohort Study
Duncan JL., Harrild KA., Iversen L., et al. BMJ 2012;344:e2958 [doi:
10.1136/bmj,e2958].
Conclusion: Men with abdominal aortic aneurysm (AAA) and those
with abdominal aortic diameters between 25 and 29 mm have increased risk
of mortality and subsequent hospital admission compared with men with
abdominal aortas with diameters 24 mm.
Summary: Screening ultrasound studies of men aged 65 years have
been shown to be cost-effective in reducing aortic aneurysm-related mortal-
ity, with benefits extending to at least 10 years (Thompson SG et al, BMJ
2009;338:b2307). However, aneurysm screening does not reduce all-cause
mortality, and this may be partly due to increased risk of mortality of other
vascular disease in patients with AAA (Brady AR et al, Arterioscler Thromb
Vasc Biol 2001;21:1203-7). Most screening studies use a threshold aortic
diameter of 30 mm as the definition of an AAA. Patients with abdominal
aortas at or above this level are entered into a follow-up program, and those
with abdominal aortas 30 mm are reassured and not reappointed for
t
tollow-up. However, there is a possible association between aortic diameter
nd mortality, suggesting that patients just below the threshold level of 30
m for continued aortic follow-up may still be at an increased risk for
ascular-related events (Freiberg MS et al, Circulation 2008;117:1010-7).
he authors therefore examined morbidity and mortality in men with an
AA (aortic diameter30 mm) and those with ectatic aortas (range, 25-29
m), and comparedmorbidity andmortality rates withmen with abdominal
ortas 24 mm at the time of the initial aneurysm screening study. The
tudy was performed in a large, sparsely populated area of Scotland and
ncluded 8146 men aged 65 to 74 years. The main outcome measure was
orbidity and mortality with respect to the abdominal aorta in three size
ategories:24, 25-29, and30 mm. After screening, 414 men (5.1%) had
n AAA with an aortic diameter of 30 mm, 696 (8.2%) had aortic
iameters of 25 to 29 mm, and 7063 (86.7%) had aortic diameters of 24
m. The men were followed up for a median of 7.4 years (interquartile
ange, 6.9-8.2 years). There was a significant association of aortic diameter
ith mortality: 512 deaths (7.2%) occurred in the group with aortas of24
m diameter compared with 69 deaths (10.3%) in the 25- to 29-mm group
nd 73 deaths (17.6%) in men with aortic diameters30mm.Differences in
ortality were significant, with the mortality risk in men with an aneurysm
nd in those with an aorta measuring 25 to 29 mm being significantly higher
han in men with aortas24 mm.Mortality risk in the 25- to 29-mm group
as reduced after taking into account confounders such as smoking and
nown heart disease. However, after adjustment, risk of hospital admission
or cardiovascular disease and chronic obstructive pulmonary disease was
igher in men with an aneurysm and in men with aortas measuring 25 to 29
m compared with men with an aortic diameter of 24 mm. Men with
neurysms had an increased risk of hospitalization for atherosclerotic periph-
ral artery disease, cerebrovascular disease, and respiratory disease. In men
ith aortas of 25 to 29 mm, risk of hospital admission was also higher than
nmenwith an aorta of24mm (adjusted hazard ratio, 6.7; 95% confidence
nterval, 3.42-13.2). This increased risk became apparent 2 years after
creening.
Comment: The data indicate that it is possible to stratify risks of
ardiovascular disease by abdominal aortic diameter. Patients with AAA,
bdominal aortas 30 mm, have an increased risk of cardiovascular disease
ompared with patients with abdominal aortas 24 mm. Those patients
ith aortic diameters of 25 to 29mm have an increased risk of cardiovascular
isease, but the risk disappears when confounders, such as smoking and
ypertension, are taken into account. However, patients with 25- to 29-mm
ortas still have an increased subsequent risk of hospital admission due to
ypertension, ischemic heart disease, heart failure, diabetes mellitus, and
hronic obstructive pulmonary disease. The data indicate these patients
hould not be just reassured and sent on their way. Targeted interventions to
educe subsequent hospital admissions for hypertension, ischemic heart
isease, heart failure, etc, would seem appropriate in the group of patients
ith abdominal aortas of between 25 and 29 mm in diameter.
egistry of Transcatheter Aortic-Valve Implantation in High-Risk
atients
ilardM., Eltchaninoff H., Lung B., and the France 2 Investigators. N Engl
Med 2012;336:1705-15.
Conclusion: “Real-life” experience of transcatheter aortic valve im-
lantation (TAVI) in elderly patients, with a high prevalence of coexisting
llnesses, demonstrates acceptable complication rates.
Summary: Aortic stenosis is the most frequently diagnosed valvular
ardiac condition. In elderly patients at good risk, operative mortality after
ortic valve placement is low but increases dramatically with severity of
oexisting illnesses (Melby SJ et al. Ann Thorac Surg 2007;83:1651-7).
ribier et al implanted the first transcatheter aortic valve 10 years ago
Circulation 2002;106:3006-8). Since then, 50,000 patients have been
reated by TAVI around the world. One randomized trial compared TAVI
ith medical therapy in patients where surgery was contraindicated (Leon
B et al, N Engl J Med 2010;363:1597-607). Most TAVI data is therefore
egistry data. In France, the France 2 registry is a prospective multicenter
tudy of the French experience with TAVI. In this report, all TAVIs
reformed in France, as listed in the France 2 registry, were prospectively
nalyzed with a primary end point of death from any cause. Between January
010 and October 2011, at 34 centers, 3,195 patients (49% women) were
nrolled in the France 2 TAVI registry. Median age was 82.7 7.2 years. All
atients were considered at high surgical risk for open aortic valve replace-
ent and were considered to be severely symptomatic. Edwards SAPIEN
nd Medtronic Core Valve devices were implanted in 66.9% and 33.1% of
atients, respectively. Approaches were transarterial, (femoral, 74.6%; sub-
lavian, 5.8%; other, 1.8%) or transapical (17.8%). Procedural success rate
as 96.9%. The death rate was 9.7% at 30 days and 24.0% at 1 year. The
ncidence of stroke at 1 year was 4.1%, and incidence of periprosthetic aortic
egurgitation at 1 year was 64.5%. In a multivariate model, a higher logistic
isk score on the European System for Cardiac Operative Risk Evaluation
EuroSCORE) and New York Heart Association functional class III or IV,
he use of transapical TAVI, and a higher amount of periprosthetic regurgi-
ation all were significantly associated with reduced survival.
